1-4 of 4
Takayoshi Toyota
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

Nigishi Hotta, MD, Yasuo Akanuma, MD, Ryuzo Kawamori, MD, Kempei Matsuoka, MD, Yoshitomo Oka, MD, Motoaki Shichiri, MD, Takayoshi Toyota, MD, Mitsuyoshi Nakashima, MD, Isao Yoshimura, PHD, Nobuo Sakamoto, MD, Yukio Shigeta, MD, the ADCT Study Group
Journal: Diabetes Care
Diabetes Care 2006;29(7):1538–1544
https://doi.org/10.2337/dc05-2370
Published: 01 July 2006
View article titled, Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: <subtitle>The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial</subtitle>
Open the PDF for Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: <subtitle>The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial</subtitle> in another window
Journal Articles

Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy: A 52-week multicenter placebo-controlled double-blind parallel group study

Nigishi Hotta, MD, Takayoshi Toyota, MD, Kempei Matsuoka, MD, Yukio Shigeta, MD, Ryuichi Kikkawa, MD, Toshio Kaneko, MD, Akira Takahashi, MD, Kimiya Sugimura, MD, Yasuo Koike, MD, Jun Ishii, MD, Nobuo Sakamoto, MD, The SNK-860 Diabetic Neuropathy Study Group
Journal: Diabetes Care
Diabetes Care 2001;24(10):1776–1782
https://doi.org/10.2337/diacare.24.10.1776
Published: 01 October 2001
View article titled, Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy: <subtitle>A 52-week multicenter placebo-controlled double-blind parallel group study</subtitle>
Open the PDF for Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy: <subtitle>A 52-week multicenter placebo-controlled double-blind parallel group study</subtitle> in another window
Journal Articles

Urinary chiro-Inositol Excretion is an Index Marker of Insulin Sensitivity in Japanese Type II Diabetes

Susumu Suzuki, MD, Hiromasa Kawasaki, MD, Yoshinori Satoh, MD, Masataka Ohtomo, MD, Masashi Hirai, MD, Aki Hirai, MD, Satoshi Hirai, MD, Masatoshi Onoda, MD, Masahiro Matsumoto, MD, Yoshinori Hinokio, MD, Hiroaki Akai, MD, James Craig, MD, Joseph Larner, MD, PHD, Takayoshi Toyota, MD
Journal: Diabetes Care
Diabetes Care 1994;17(12):1465–1468
https://doi.org/10.2337/diacare.17.12.1465
Published: 01 December 1994
View article titled, Urinary <em>chiro</em>-Inositol Excretion is an Index Marker of Insulin Sensitivity in Japanese Type II Diabetes
Open the PDF for Urinary <em>chiro</em>-Inositol Excretion is an Index Marker of Insulin Sensitivity in Japanese Type II Diabetes in another window
Journal Articles

Diabetes With Mitochondrial Gene tRNALYS Mutation

Susumu Suzuki, MD, Yoshinori Hinokio, MD, Satoshi Hirai, MD, Masatoshi Onoda, MD, Masahiro Matsumoto, MD, Masataka Ohtomo, MD, Hiromasa Kawasaki, MD, Yoshinori Satoh, MD, Hiroaki Akai, MD, Kohji Abe, MD, Takayoshi Toyota, MD
Journal: Diabetes Care
Diabetes Care 1994;17(12):1428–1432
https://doi.org/10.2337/diacare.17.12.1428
Published: 01 December 1994
View article titled, Diabetes With Mitochondrial Gene tRNA<sup>LYS</sup> Mutation
Open the PDF for Diabetes With Mitochondrial Gene tRNA<sup>LYS</sup> Mutation in another window